« Volver al listado

CVE-2024-10476

Estado: AplazadaAlta (8)—

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.

CVSS

Probabilidad de explotación (EPSS)

EPSS (Exploit Prediction Scoring System, de FIRST) estima la probabilidad de que una vulnerabilidad sea explotada en 30 días. Complementa a CVSS (impacto) y a CISA KEV (explotación confirmada).

🎯 Técnicas ATT&CK

Cómo se explota esta vulnerabilidad y qué consigue el atacante, en el lenguaje de MITRE ATT&CK.

Credenciales por defecto en servicios remotos (BD Diagnostic Solutions) accesibles con privilegios locales (PR:L, AV:A). Impactos: autenticación con cuentas válidas, modificación de datos (PHI/PII), y disponibilidad del sistema.

Inferido por nuestro agente de análisis a partir de la descripción oficial, el vector CVSS y la CWE, y comprobado por un supervisor. Puede contener errores.

🛡️ Mitigaciones ATT&CK que cubren estas técnicas

Vulnerability ScanningThreat Intelligence ProgramRestrict File and Directory PermissionsPrivileged Account ManagementPassword PoliciesRemote Data Storage

Tecnologías afectadas (3)

⚠ Inferidas por IA a partir de la descripción — NVD aún no ha analizado esta CVE; no son CPE verificados.

BD — Diagnostic SolutionsAIBD — Kiestra SCUAIBD — Synapsys Informatics SolutionAI

CWE

Referencias

JSON original (NVD)

Mostrar
{
  "id": "CVE-2024-10476",
  "cveTags": [],
  "metrics": {
    "ssvcV203": [
      {
        "source": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
        "ssvcData": {
          "id": "CVE-2024-10476",
          "role": "CISA Coordinator",
          "options": [
            {
              "exploitation": "none"
            },
            {
              "automatable": "no"
            },
            {
              "technicalImpact": "total"
            }
          ],
          "version": "2.0.3",
          "timestamp": "2024-12-17T15:35:29.382383Z"
        }
      }
    ],
    "cvssMetricV31": [
      {
        "type": "Secondary",
        "source": "cybersecurity@bd.com",
        "cvssData": {
          "scope": "UNCHANGED",
          "version": "3.1",
          "baseScore": 8,
          "attackVector": "ADJACENT_NETWORK",
          "baseSeverity": "HIGH",
          "vectorString": "CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H",
          "integrityImpact": "HIGH",
          "userInteraction": "NONE",
          "attackComplexity": "LOW",
          "availabilityImpact": "HIGH",
          "privilegesRequired": "LOW",
          "confidentialityImpact": "HIGH"
        },
        "impactScore": 5.9,
        "exploitabilityScore": 2.1
      }
    ]
  },
  "affected": [
    {
      "source": "cybersecurity@bd.com",
      "affectedData": [
        {
          "vendor": "Becton Dickinson & Co",
          "product": "BD BACTEC™ Blood Culture System",
          "versions": [
            {
              "status": "affected",
              "version": "0",
              "versionType": "custom",
              "lessThanOrEqual": "7.20"
            }
          ],
          "defaultStatus": "affected"
        },
        {
          "vendor": "Becton Dickinson & Co",
          "product": "BD COR™ System",
          "versions": [
            {
              "status": "affected",
              "version": "0",
              "versionType": "custom",
              "lessThanOrEqual": "8.90"
            }
          ],
          "defaultStatus": "affected"
        },
        {
          "vendor": "Becton Dickinson & Co",
          "product": "BD EpiCenter™ Microbiology Data Management System",
          "versions": [
            {
              "status": "affected",
              "version": "0",
              "versionType": "custom",
              "lessThanOrEqual": "7.45"
            }
          ],
          "defaultStatus": "affected"
        },
        {
          "vendor": "Becton Dickinson & Co",
          "product": "BD MAX™ System",
          "versions": [
            {
              "status": "affected",
              "version": "0",
              "versionType": "custom",
              "lessThanOrEqual": "6.10"
            }
          ],
          "defaultStatus": "affected"
        },
        {
          "vendor": "Becton Dickinson & Co",
          "product": "BD Phoenix™ M50 Automated Microbiology System",
          "versions": [
            {
              "status": "affected",
              "version": "0",
              "versionType": "custom",
              "lessThanOrEqual": "2.70"
            }
          ],
          "defaultStatus": "affected"
        },
        {
          "vendor": "Becton Dickinson & Co",
          "product": "BD Synapsys™ Informatics Solution",
          "versions": [
            {
              "status": "affected",
              "version": "0",
              "versionType": "custom",
              "lessThanOrEqual": "6.10"
            }
          ],
          "defaultStatus": "affected"
        }
      ]
    }
  ],
  "published": "2024-12-17T16:15:23.390",
  "references": [
    {
      "url": "https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/bd-cybersecurity-vulnerability-bulletin-diagnostic-solutions-products",
      "source": "cybersecurity@bd.com"
    }
  ],
  "vulnStatus": "Deferred",
  "weaknesses": [
    {
      "type": "Secondary",
      "source": "cybersecurity@bd.com",
      "description": [
        {
          "lang": "en",
          "value": "CWE-1392"
        }
      ]
    }
  ],
  "descriptions": [
    {
      "lang": "en",
      "value": "Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics\nSolution is only in scope of\nthis vulnerability when\ninstalled on a NUC server. BD Synapsys™\nInformatics Solution installed\non a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is\nnot in scope."
    },
    {
      "lang": "es",
      "value": "Las credenciales predeterminadas se utilizan en BD Diagnostic Solutions products enumerados anteriormente. Si se explota esta vulnerabilidad, los actores de amenazas pueden acceder, modificar o eliminar datos, incluida información confidencial como información médica protegida (PHI) e información de identificación personal (PII). La explotación de esta vulnerabilidad puede permitir que un atacante apague o afecte de otro modo la disponibilidad del sistema. Nota: BD Synapsys™ Informatics Solution solo está dentro del alcance de esta vulnerabilidad cuando se instala en un servidor NUC. BD Synapsys™ Informatics Solution instalada en una máquina virtual proporcionada por el cliente o en el hardware BD Kiestra™ SCU no está dentro del alcance."
    }
  ],
  "lastModified": "2026-06-17T06:55:45.400",
  "sourceIdentifier": "cybersecurity@bd.com"
}